Rajajeyabalachandran, Gurukumari <br/><br/>
Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents.  [electronic resource] 

 -  Expert opinion on therapeutic targets  Feb 2017 
 - 145-157 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7631 
<br/><br/><label>Standard No.: </label>10.1080/14728222.2017.1272580  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--administration & dosage<br/>Drug Design<br/>Drug Synergism<br/>Epigenesis, Genetic<br/>Gene Expression Regulation, Neoplastic<br/>Histone-Lysine N-Methyltransferase--genetics<br/>Humans<br/>Molecular Targeted Therapy<br/>Neoplasms--drug therapy<br/>Prognosis